InspireMD (NSPR) Total Current Liabilities (2010 - 2025)
InspireMD's (NSPR) quarterly Total Current Liabilities came in at $10.7 million in Q4 2025, up 39.52% year-on-year from $7.7 million in Q4 2024, and down 0.96% quarter-over-quarter from $10.8 million in Q3 2025.
InspireMD (NSPR) Total Current Liabilities (2010 - 2025) Analysis & Trends
InspireMD's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $10.7 million for Q4 2025.
- On a quarterly basis, Total Current Liabilities rose 39.52% year-over-year to $10.7 million in Q4 2025; TTM through Dec 2025 was $10.7 million, a 39.52% increase from a year earlier, with the FY2025 full-year figure at $10.7 million, up 39.52% from the prior year.
- Total Current Liabilities eased to $10.7 million in Q4 2025 per NSPR's latest filing, from $10.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $10.8 million in Q3 2025 and bottomed at $2.9 million in Q1 2021.
- The 5-year median for Total Current Liabilities is $4.9 million (2023), against an average of $5.8 million.
- Across the five-year window, Total Current Liabilities increased 2.48% in 2023 and surged 54.9% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $4.3 million in 2021, then climbed by 16.63% to $5.1 million in 2022, then advanced by 18.74% to $6.0 million in 2023, then rose by 27.54% to $7.7 million in 2024, then surged by 39.52% to $10.7 million in 2025.
- Per Business Quant, the three latest NSPR Total Current Liabilities figures stand at $10.7 million (Q4 2025), $10.8 million (Q3 2025), and $9.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | 10.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.71 Mn |
| Sep 30, 2025 | 10.82 Mn |
| Jun 30, 2025 | 9.07 Mn |
| Mar 31, 2025 | 7.37 Mn |
| Dec 31, 2024 | 7.68 Mn |
| Sep 30, 2024 | 7.27 Mn |
| Jun 30, 2024 | 6.97 Mn |
| Mar 31, 2024 | 4.88 Mn |
| Dec 31, 2023 | 6.02 Mn |
| Sep 30, 2023 | 4.69 Mn |
| Jun 30, 2023 | 4.83 Mn |
| Mar 31, 2023 | 4.38 Mn |
| Dec 31, 2022 | 5.07 Mn |
| Sep 30, 2022 | 3.96 Mn |
| Jun 30, 2022 | 4.71 Mn |
| Mar 31, 2022 | 3.69 Mn |
| Dec 31, 2021 | 4.35 Mn |
| Sep 30, 2021 | 3.72 Mn |
| Jun 30, 2021 | 3.68 Mn |
| Mar 31, 2021 | 2.87 Mn |